278 related articles for article (PubMed ID: 9514418)
21. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
Mao SJ; Yates MT; Parker RA; Chi EM; Jackson RL
Arterioscler Thromb; 1991; 11(5):1266-75. PubMed ID: 1911712
[TBL] [Abstract][Full Text] [Related]
22. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits.
Tijburg LB; Wiseman SA; Meijer GW; Weststrate JA
Atherosclerosis; 1997 Nov; 135(1):37-47. PubMed ID: 9395271
[TBL] [Abstract][Full Text] [Related]
23. Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits.
Bocan TM; Mueller SB; Brown EQ; Uhlendorf PD; Mazur MJ; Newton RS
Exp Mol Pathol; 1992 Aug; 57(1):70-83. PubMed ID: 1397193
[TBL] [Abstract][Full Text] [Related]
24. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V
Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494
[TBL] [Abstract][Full Text] [Related]
25. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.
Fruebis J; Bird DA; Pattison J; Palinski W
J Lipid Res; 1997 Dec; 38(12):2455-64. PubMed ID: 9458269
[TBL] [Abstract][Full Text] [Related]
26. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
[TBL] [Abstract][Full Text] [Related]
27. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
Daugherty A; Zweifel BS; Schonfeld G
Br J Pharmacol; 1991 May; 103(1):1013-8. PubMed ID: 1878742
[TBL] [Abstract][Full Text] [Related]
28. In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide.
Breugnot C; Iliou JP; Privat S; Robin F; Vilaine JP; Lenaers A
J Cardiovasc Pharmacol; 1992 Sep; 20(3):340-7. PubMed ID: 1279277
[TBL] [Abstract][Full Text] [Related]
29. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis.
Morel DW; de la Llera-Moya M; Friday KE
J Nutr; 1994 Nov; 124(11):2123-30. PubMed ID: 7965195
[TBL] [Abstract][Full Text] [Related]
30. Alpha-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits.
Schwenke DC; Behr SR
Free Radic Biol Med; 2001 Sep; 31(6):778-89. PubMed ID: 11557316
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
Sasahara M; Raines EW; Chait A; Carew TE; Steinberg D; Wahl PW; Ross R
J Clin Invest; 1994 Jul; 94(1):155-64. PubMed ID: 8040256
[TBL] [Abstract][Full Text] [Related]
32. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.
Sparrow CP; Doebber TW; Olszewski J; Wu MS; Ventre J; Stevens KA; Chao YS
J Clin Invest; 1992 Jun; 89(6):1885-91. PubMed ID: 1601995
[TBL] [Abstract][Full Text] [Related]
33. Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis.
Itoh S; Umemoto S; Hiromoto M; Toma Y; Tomochika Y; Aoyagi S; Tanaka M; Fujii T; Matsuzaki M
Circulation; 2002 May; 105(19):2288-95. PubMed ID: 12010912
[TBL] [Abstract][Full Text] [Related]
34. Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth.
Doggrell SA
Expert Opin Investig Drugs; 2003 Nov; 12(11):1855-9. PubMed ID: 14585060
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
Mao SJ; Yates MT; Rechtin AE; Jackson RL; Van Sickle WA
J Med Chem; 1991 Jan; 34(1):298-302. PubMed ID: 1992130
[TBL] [Abstract][Full Text] [Related]
36. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit.
Dabbagh AJ; Shwaery GT; Keaney JF; Frei B
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2638-45. PubMed ID: 9409237
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of human low-density lipoprotein oxidation by salvianolic acid-A].
Liu YL; Liu GT
Yao Xue Xue Bao; 2002 Feb; 37(2):81-5. PubMed ID: 12579947
[TBL] [Abstract][Full Text] [Related]
38. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.
Hayek T; Attias J; Smith J; Breslow JL; Keidar S
J Cardiovasc Pharmacol; 1998 Apr; 31(4):540-4. PubMed ID: 9554802
[TBL] [Abstract][Full Text] [Related]
39. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
40. Dietary hematein ameliorates fatty streak lesions in the rabbit by the possible mechanism of reducing VCAM-1 and MCP-1 expression.
Oh GT; Choi JH; Hong JJ; Kim DY; Lee SB; Kim JR; Lee CH; Hyun BH; Oh SR; Bok SH; Jeong TS
Atherosclerosis; 2001 Nov; 159(1):17-26. PubMed ID: 11689202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
